Geode Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,320,862 shares of FULC stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,320,862
Previous 1,307,377 1.03%
Holding current value
$3.98 Million
Previous $8.11 Million 41.83%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$3.18 - $9.74 $42,882 - $131,343
13,485 Added 1.03%
1,320,862 $4.72 Million
Q2 2024

Aug 09, 2024
BUY
$5.98 - $9.31 $4.45 Million - $6.93 Million
743,919 Added 132.03%
1,307,377 $8.11 Million
Q1 2024

May 13, 2024
BUY
$6.7 - $12.0 $68,527 - $122,736
10,228 Added 1.85%
563,458 $5.32 Million
Q4 2023

Feb 13, 2024
BUY
$3.18 - $6.86 $59,551 - $128,467
18,727 Added 3.5%
553,230 $3.73 Million
Q3 2023

Nov 13, 2023
SELL
$3.25 - $6.08 $101,744 - $190,340
-31,306 Reduced 5.53%
534,503 $2.37 Million
Q2 2023

Aug 11, 2023
SELL
$2.26 - $3.8 $1.12 Million - $1.89 Million
-496,825 Reduced 46.75%
565,809 $1.87 Million
Q1 2023

May 15, 2023
BUY
$2.83 - $13.99 $585,249 - $2.89 Million
206,802 Added 24.16%
1,062,634 $3.03 Million
Q4 2022

Feb 13, 2023
BUY
$5.01 - $8.35 $1.16 Million - $1.93 Million
230,762 Added 36.92%
855,832 $6.23 Million
Q3 2022

Nov 14, 2022
BUY
$4.92 - $9.1 $288,100 - $532,868
58,557 Added 10.34%
625,070 $5.06 Million
Q2 2022

Aug 12, 2022
BUY
$4.2 - $24.0 $152,779 - $873,024
36,376 Added 6.86%
566,513 $2.78 Million
Q1 2022

May 13, 2022
BUY
$9.96 - $23.65 $320,034 - $759,921
32,132 Added 6.45%
530,137 $12.5 Million
Q4 2021

Feb 11, 2022
BUY
$14.0 - $28.44 $553,882 - $1.13 Million
39,563 Added 8.63%
498,005 $8.81 Million
Q3 2021

Nov 12, 2021
BUY
$7.28 - $30.97 $741,468 - $3.15 Million
101,850 Added 28.56%
458,442 $12.9 Million
Q2 2021

Aug 13, 2021
BUY
$8.09 - $12.0 $581,306 - $862,260
71,855 Added 25.24%
356,592 $3.74 Million
Q1 2021

May 12, 2021
BUY
$10.94 - $15.32 $843,112 - $1.18 Million
77,067 Added 37.11%
284,737 $3.35 Million
Q4 2020

Feb 12, 2021
BUY
$7.84 - $13.4 $467,162 - $798,465
59,587 Added 40.24%
207,670 $2.43 Million
Q3 2020

Nov 13, 2020
BUY
$7.22 - $20.7 $158,558 - $454,592
21,961 Added 17.41%
148,083 $1.17 Million
Q2 2020

Aug 13, 2020
BUY
$9.11 - $22.06 $52,109 - $126,183
5,720 Added 4.75%
126,122 $2.31 Million
Q1 2020

May 14, 2020
BUY
$9.49 - $21.26 $585,542 - $1.31 Million
61,701 Added 105.11%
120,402 $1.44 Million
Q4 2019

Feb 13, 2020
BUY
$4.46 - $18.14 $137,858 - $560,707
30,910 Added 111.22%
58,701 $976,000
Q3 2019

Nov 12, 2019
BUY
$6.64 - $14.89 $184,532 - $413,807
27,791 New
27,791 $184,000

Others Institutions Holding FULC

# of Institutions
150
Shares Held
52.2M
Call Options Held
6.91M
Put Options Held
1.9M
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $157M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email